(Q37905690)

25 August 2017

1 reference

title

Lung cancer and Toll-like receptors (English)

1 reference

25 August 2017

0 references

1 reference

Aldo Pinto

1

1 reference

25 August 2017

Silvana Morello

series ordinal

2

1 reference

25 August 2017

Rosalinda Sorrentino

series ordinal

3

1 reference

25 August 2017

language of work or name

1 reference

26 July 2011

1 reference

Cancer Immunology, Immunotherapy

25 August 2017

1 reference

25 August 2017

60

1 reference

25 August 2017

9

1 reference

25 August 2017

1211-1220

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-011-1057-8

25 August 2017

0 references

cites work

Immune escape as a fundamental trait of cancer: focus on IDO.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Regulatory T cells and Toll-like receptors in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Toll-like receptors, wound healing, and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Toll-like receptors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Pattern recognition receptors and interleukin-8 mediate effects of Gram-positive and Gram-negative bacteria on lung epithelial cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Toll-like receptors in the respiratory system: their roles in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Toll-like receptors expressed in tumor cells: targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Role of CD83 in the immunomodulation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Division of labor with a workforce of one: challenges in specifying effector and memory T cell fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

The master regulators of allergic inflammation: dendritic cells in Th2 sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

MyD88-dependent induction of allergic Th2 responses to intranasal antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

The role of dendritic and epithelial cells as master regulators of allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Development of TLR9 agonists for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Phenotype of dendritic cells generated in the presence of non-small cell lung cancer antigens - preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Plasmacytoid dendritic cells prevent cigarette smoke and Chlamydophila pneumoniae-induced Th2 inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

IDO: a double-edged sword for T(H)1/T(H)2 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Toll-like Receptors and Their Signaling Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Prostaglandin E2 inhibits IFN-alpha secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Inhibiting survivin expression enhances TRAIL-induced tumoricidal activity in human hepatocellular carcinoma via cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Isolation, expansion, and characterization of human natural and adaptive regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Developmental plasticity of Th17 and Treg cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Regulating B-cell activation and survival in response to TLR signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Inhibitory effects of B cells on antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Macrophages and fibroblasts during inflammation, tissue damage and organ injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Regulatory myeloid suppressor cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Toll-like receptor signaling in cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

TLR-dependent activation stimuli associated with Th1 responses confer NK cell stimulatory capacity to mouse dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Mast cells as target in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Effect of mast cells on tumor angiogenesis in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Accumulation of Peribronchial Mast Cells in a Mouse Model of Ovalbumin Allergen Induced Chronic Airway Inflammation: Modulation by Immunostimulatory DNA Sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Human lung cancer cells express functionally active Toll-like receptor 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Lung vascular endothelial growth factor expression induces local myeloid dendritic cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

CpG DNA-mediated immune response in pulmonary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: involvement of programmed death-1 and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1057-8

10.1007/S00262-011-1057-8

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference